Difficulty: Medium
Average Score: 77%
Practice
Which of the following best describes an abnormality in structure or function that occurs during fetal development?
Correct answer
A
Rationale
In the context of pharmacology and health promotion, understanding the terminology related to developmental abnormalities is crucial. The correct answer to the question is A) Congenital defect. A congenital defect refers to an abnormality in structure or function that is present at birth and often arises during fetal development. This can be due to a variety of factors such as environmental influences, maternal health, or genetic predispositions.
Option B) Genetic defect specifically refers to abnormalities that are caused by variations in the individual's genes, which may or may not manifest at birth. While genetic defects can contribute to congenital defects, they are not synonymous.
Option C) Embryonic defect and Option D) Chromosomal defect also play a role in developmental abnormalities but are more specific in nature. Embryonic defects occur during the early stages of development, typically within the first eight weeks after conception, while chromosomal defects involve changes in the structure or number of chromosomes. These terms are more narrowly focused compared to the broader category of congenital defects.
In an educational context, grasping these distinctions is essential for healthcare professionals, especially pharmacologists, as they need to understand the underlying causes of developmental abnormalities to provide appropriate care and interventions. By recognizing the differences between congenital, genetic, embryonic, and chromosomal defects, professionals can tailor their approaches to health promotion and management strategies for individuals affected by these conditions.
Option B) Genetic defect specifically refers to abnormalities that are caused by variations in the individual's genes, which may or may not manifest at birth. While genetic defects can contribute to congenital defects, they are not synonymous.
Option C) Embryonic defect and Option D) Chromosomal defect also play a role in developmental abnormalities but are more specific in nature. Embryonic defects occur during the early stages of development, typically within the first eight weeks after conception, while chromosomal defects involve changes in the structure or number of chromosomes. These terms are more narrowly focused compared to the broader category of congenital defects.
In an educational context, grasping these distinctions is essential for healthcare professionals, especially pharmacologists, as they need to understand the underlying causes of developmental abnormalities to provide appropriate care and interventions. By recognizing the differences between congenital, genetic, embryonic, and chromosomal defects, professionals can tailor their approaches to health promotion and management strategies for individuals affected by these conditions.